(Q56039693)

1

0 references

G.V. De Lucca

2

0 references

A.C. Bach

3

0 references

R.S. Pottorf

4

0 references

J.M. Blaney

Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution

5

0 references

publication date

March 1993

0 references

published in

Tetrahedron

0 references

volume

49

0 references

issue

17

0 references

page(s)

3593-3608

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

The crystal structures of recombinant glycosylated human renin alone and in complex with a transition state analog inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Emerging principles for the recognition of peptide antigens by MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Target enzyme recognition by calmodulin: 2.4 A structure of a calmodulin-peptide complex

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Solution structure of a calmodulin-target peptide complex by multidimensional NMR

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Structural evidence for induced fit as a mechanism for antibody-antigen recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

1 reference

7 January 2021

Turns in peptides and proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Stereochemical criteria for polypeptides and proteins. V. Conformation of a system of three linked peptide units

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Chain reversals in proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

1 reference

7 January 2021

A potent cyclic hexapeptide analogue of somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

half-Cys4,half-Cys10-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Bioactive conformation of luteinizing hormone-releasing hormone: evidence from a conformationally constrained analog

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Molecular structure of a cyclic tetrapeptide disulfide. A novel 310 helical conformation with an S-S bridge

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Evidence for the bioactive conformation in a cyclic hexapeptide analogue of somatostatin containing a cis-peptide bond mimic

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

A convenient preparation of derivatives of 3(s)-amino-10(r)-carboxy-1,6-diaza-cyclodeca-2,7-dione the dilactam of L-α, γ-diaminobutyric acid and d-glutamic acid: A β-turn template

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

A new approach to conformationally restricted peptide analogs: rigid beta-bends. 1. Enkephalin as an example

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

The design and synthesis of mimetics of peptide beta-turns

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

On the biologically active structures of cholecystokinin, little gastrin, and enkephalin in the gastrointestinal system

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

An opioid benzodiazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Effects of Ro 16-0521 on cholesterol metabolism in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Pyrrolo[1,4]benzodiazepine antitumor antibiotics: evidence for two forms of tomaymycin bound to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Bicyclic and tricyclic analogues of anthramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Derivatives of tetrahydro-1,4-benzodiazepines as potential antihypertensive agents

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021

Conformations of (X-L-Pro-Y)2 cyclic hexapeptides. Preferred .beta.-turn conformers and implications for .beta. turns in proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0040-4020%2801%2990217-0

7 January 2021